The analysis of miR-33b and EZH2 in other BC subtypes showed as well a significant higher expression of miR-33b in control cell lines vs cancer cell lines and an oppositely significant higher expression of EZH2 on cancer cell lines in comparison with those of the controls (Supplementary Figures 1A,C). The gene discussed is EZH2; the disease is breast cancer.